Form 4: USANA Health Sciences Director Timothy E. Wood Reports Stock Transactions
SEC Form 4 Filing
Director Timothy E. Wood of USANA Health Sciences Inc. reported the acquisition of 674 common stock units and the disposal of 169 common stock units on February 2, 2025.
Summary
- Timothy E. Wood, a director at USANA Health Sciences Inc., filed a Form 4 disclosing changes in his beneficial ownership of the company's stock.
- On February 2, 2025, Mr. Wood acquired 674 shares of common stock through the vesting of restricted stock units.
- Also on February 2, 2025, Mr. Wood disposed of 169 shares of common stock at a price of $32.57 per share.
- Following these transactions, Mr. Wood directly owns 6,937 shares of USANA common stock.
- The restricted stock units vest in four tranches: 25% on August 2, 2024, November 2, 2024, February 2, 2025, and May 2, 2025.
Sentiment
Score: 5
Explanation: The document is a routine disclosure of stock transactions by a company director, which is neither positive nor negative in itself. It is a neutral event.
Industry Context
This filing is a routine disclosure of stock transactions by a company insider, which is common practice for publicly traded companies. It provides transparency into the trading activities of key personnel.
Comparison to Industry Standards
- Form 4 filings are standard practice for publicly traded companies in the US, as mandated by the Securities and Exchange Commission (SEC).
- Similar filings are made by directors and officers of companies like Herbalife Nutrition (HLF) and Nu Skin Enterprises (NUS), which are also in the health and wellness industry.
- The transactions reported are typical for executives receiving stock-based compensation and do not indicate any unusual activity.
Stakeholder Impact
- The transactions have a minimal impact on shareholders as they are routine and do not indicate any significant change in the company's outlook.
- The transactions are part of the standard compensation package for the director.
Key Dates
| Date | Description |
|---|---|
| 08/02/2024 | First vesting date for 25% of the restricted stock units. |
| 11/02/2024 | Second vesting date for 25% of the restricted stock units. |
| 02/02/2025 | Third vesting date for 25% of the restricted stock units, also the date of the reported transactions. |
| 05/02/2025 | Final vesting date for 25% of the restricted stock units. |
| 02/03/2025 | Date the Form 4 was signed. |
Keywords
USANA Health Sciences, Form 4, insider trading, stock transaction, beneficial ownership, restricted stock units, director, equity securities
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.